<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="129380">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01821976</url>
  </required_header>
  <id_info>
    <org_study_id>W8XWH-10-2-0090</org_study_id>
    <nct_id>NCT01821976</nct_id>
  </id_info>
  <brief_title>Transtibial Amputation Outcomes Study</brief_title>
  <acronym>TAOS</acronym>
  <official_title>Transtibial Amputation Outcomes Study (TAOS): Comparing Transtibial Amputation With and Without a Tibia-fibula Synostosis (Ertl) Procedure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Major Extremity Trauma Research Consortium</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Major Extremity Trauma Research Consortium</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of the TAOS study is to determine the best procedure for below the knee
      amputations. There are two different procedures currently used by surgeons around the
      country: the Ertl procedure and the Burgess procedure. We do not know what procedure is best
      for patients. The TAOS study will help us find out which of these two procedures is best.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      High-energy open fractures, blast, gunshot wound and crush injuries to the distal tibia,
      ankle, hind foot and midfoot are common challenges to military and civilian trauma surgeons
      (Brown, 2009; Covey, 2002; Ficke, 2007; McGuigan, 2007; Hansen, 2001). Many surgeons believe
      that an early transtibial amputation provides a better long term functional outcome than
      limb salvage for these injuries (Hansen, 2001; Myerson, 1994; Sanders, 1992; Turchin,1999;
      Shawen, 2010;Ellington 2012).  If a transtibial amputation is selected as the treatment for
      the patient, a controversy remains regarding the appropriate amputation technique. Many
      surgeons advocate for an amputation with a tibia-fibula synostosis technique (Ertl
      procedure) in young and active patients, believing that this procedure provides a better
      prosthetic interface, an end bearing capacity and soft tissue stability that improves
      performance and functional outcomes. (Pinto 2004; Pinzur 2006; Commuri 2010). Others
      strongly advocate for a standard posterior flap (Burgess procedure) without the synostosis,
      arguing that patients have similar outcomes with fewer complications and lower costs.
      (Pinzur 2008; Tindle 2011) To date, the outcomes of the transtibial amputation techniques
      have not been subjected to an appropriately powered prospective randomized clinical trial.

      The primary study objective is to compare functional outcomes and number of revision
      surgeries to the amputated limb after first amputation for patients undergoing a transtibial
      amputation and randomized to receive a tibia-fibula synostosis (Ertl procedure) versus a
      standard posterior flap procedure (Burgess procedure).

      The secondary study objectives are to compare levels of impairment for patients undergoing a
      transtibial amputation and randomized to receive a tibia-fibula synostosis (Ertl procedure)
      versus a standard posterior flap procedure (Burgess procedure); to compare levels of pain
      for patients undergoing a transtibial amputation and randomized to receive a tibia-fibula
      synostosis (Ertl procedure) versus a standard posterior flap procedure (Burgess procedure);
      and to compare initial hospitalization and overall treatment costs (through the 18 month
      follow-up) for patients undergoing a transtibial amputation and are randomized to receive a
      tibia-fibula synostosis (Ertl procedure) versus a standard posterior flap procedure (Burgess
      procedure).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Patient Reported Function</measure>
    <time_frame>18 Months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Patient reported function as measured using the Short Form Musculoskeletal Assessment (SMFA) 18 months following amputation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Revision Surgeries</measure>
    <time_frame>18 Months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Number of revision surgeries to the amputated limb within 18 months after the first amputation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Physical Impairment</measure>
    <time_frame>18 Months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Physical impairment determined using objective performance measures of agility, strength/power, speed, endurance and balance as well as overall activity measured using the Step Watch activity monitor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>18 Months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Pain measured using the Brief Pain Inventory (BPI) questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment Costs</measure>
    <time_frame>18 Months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Initial hospitalization and overall treatment costs as determined from hospitals bills and  data on utilization of outpatient health services</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Transtibial Amputation</condition>
  <arm_group>
    <arm_group_label>Ertl Procedure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients randomized to the Ertl Procedure Arm will receive an amputation very similar to the Burgess Procedure, except the surgeon will perform an additional step to make the cut end of the tibia bone heal to the cut end of the fibula bone with a bone bridge. This bone bridge connects the two bones together.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Burgess Procedure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients randomized to the Burgess Procedure Arm will receive a below the knee amputation where the bone is cut and skin and muscle from the back of the leg are rotated to cover the cut end of your bone.  This provides good soft tissue padding to the bone and a good shape to the leg for later fitting of your prosthesis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ertl Procedure</intervention_name>
    <arm_group_label>Ertl Procedure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Burgess Procedure</intervention_name>
    <arm_group_label>Burgess Procedure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ages 18 and 60 inclusive

          -  Patients requiring a unilateral transtibial amputation following major limb trauma
             regardless of when the injury occurred

          -  The injury and its treatment must meet the following criteria:

               -  The residual fibula is not fractured or fractured and stabilized by internal
                  fixation  allowing for either the Ertl or Burgess procedure

               -  Proximal tibia/fibula joint is stabilized

               -  Soft tissue coverage allows for atypical closure and skin graft &lt;100 cm2

               -  Amputation will result in a residual limb  that is â‰¥10 cm  from joint line to
                  end of tibia

        Exclusion Criteria:

          -  At time of consent, patient has a Glasgow Coma Scale (GCS) motor score of 0-4 or a
             GCS motor score of 5 with a significant traumatic brain injury (defined as an AIS
             code of 5 or 6)

          -  Patients with wound closure requiring a free tissue transfer

          -  Fibula fractures proximal to the tibial bone cut that cannot be stabilized

          -  Late amputation with presence of one of the following conditions: (i) infection
             within the  zone of injury; (ii) chronic regional pain syndrome; (iii) post-traumatic
             thrombophlebitis

          -  Patient has a spinal cord deficit

          -  Patient has a previous leg or foot amputation or is non-ambulatory pre-injury

          -  Patient has third degree burns on &gt;10% total surface area affecting the study limb

          -  Patient has a documented psychiatric disorder

          -  Patient is unable to speak either English or Spanish

          -  Severe problems with maintaining follow-up (e.g. patients who are prisoners or
             homeless at the time of injury or who are intellectually challenged without adequate
             family support).

          -  Patient has an amputation to one or both upper extremities (excluding digits)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Michael J Bosse, MD</last_name>
    <phone>704-355-6046</phone>
    <email>michael.bosse@carolinashealthcare.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Naval Medical Center San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92134</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>James E Toledano, MD, MC, USN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California San Francisco Medical Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Theodore Miclau, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Miami Ryder Trauma Center</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Gregory A Zych, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Florida Orthopaedic Institute</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Roy Sanders, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Iowa Hospitals &amp; Clinics</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lawrence Marsh, MD</last_name>
      <email>j-marsh@uiowa.edu</email>
    </contact>
    <contact_backup>
      <last_name>Brian Westerlind</last_name>
      <email>bwesterlind@healthcare.uiowa.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Lawrence Marsh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Maryland/R Adams Cowley Shock Trauma Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>212101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Robert O'Toole, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Walter Reed National Military Medical Center</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20889</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Orthopaedic Associates of Michigan, Spectrum Health</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Clifford B Jones, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hennepin County Medical Center</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55430</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Andrew Schmidt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Mississippi Medical Center</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39216</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Robert McGuire, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Barnes Jewish Hospital</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Michael J Gardner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Louis University Medical Center</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Lisa Cannada, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Carolinas Medical Center</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Duke University Hospital</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Robert Zura, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wake Forest University Baptist Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Robert Teasdall, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MetroHealth Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Heather A Vallier, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Oklahoma</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>David Teague, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Penn State University M.S. Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>J. Spence Reid, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rhode Island Hospital, Brown University</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02903</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Roman Hayda, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>William T. Obremskey, MD, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Tech University Health Science Center at El Paso</name>
      <address>
        <city>El Paso</city>
        <state>Texas</state>
        <zip>79905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Amr Abdelgawad Abdelgawad, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>San Antonio Miliary Medical Center</name>
      <address>
        <city>Ft. Sam Houston</city>
        <state>Texas</state>
        <zip>78234-6315</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Joseph R Hsu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Virginia</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>David Weiss, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Naval Medical Center Portsmouth</name>
      <address>
        <city>Portsmouth</city>
        <state>Virginia</state>
        <zip>23708</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Robert Gaines, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <lastchanged_date>March 27, 2013</lastchanged_date>
  <firstreceived_date>March 27, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
